Lataa...
Sustained enhancement of OCTN1 transporter expression in association with hydroxyurea induced gamma-globin expression in erythroid progenitors
The clinical benefits of hydroxyurea treatment in patients with sickle cell disease (SCD) are due largely to increased gamma-globin expression. However, mechanisms that control gamma-globin expression by hydroxyurea in erythroid progenitors are incompletely understood. Here, we investigated the role...
Tallennettuna:
| Julkaisussa: | Exp Hematol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5164842/ https://ncbi.nlm.nih.gov/pubmed/27616638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2016.09.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|